Muscle-building supplement use and increased risk of testicular germ cell cancer in men from Connecticut and Massachusetts
Year: 2015
Type: article
Study design: Observational Study
Abstract: BACKGROUND: No analytic epidemiological study has examined the relationship between use of muscle-building supplements (MBSs) and testicular germ cell cancer (TGCC) risk. METHODS: We conducted a population-based case-control study including 356 TGCC cases and 513 controls from Connecticut and Massachusetts. RESULTS: The odds ratio (OR) for ever use of MBSs in relation to risk of TGCC was significantly elevated (OR=1.65, 95% confidence interval (CI): 1.11-2.46). The associations were significantly stronger among early users, men with more types of MBSs used, and longer periods of use. CONCLUSIONS: MBS use is a potentially modifiable risk factor that may be associated with TGCC.
Source: British Journal of Cancer
DOI: 10.1038/bjc.2015.26
Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Yale University, Harvard University, Fred Hutch Cancer Center, International Prevention Research Institute, Cancer Hospital of Chinese Academy of Medical Sciences, Nanjing Medical University, Massachusetts General Hospital
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,190
OpenAlex ID: W1983607652
